Login
Super Investors MFS New Discovery Fund

MFS New Discovery Fund

Mfs Series Trust I · net assets $2.14B · 118 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 97.8% · STIV: 2.2% · DE: 0.0%

Financial position

Total assets
$2.19B
Total liabilities
$49.8M
Net assets
$2.14B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$2.61M

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $9.08M $10.1M $9.8M
Reinvestment $0 $0 $0
Redemptions $47M $41.7M $40.7M
Net realized gain (non-derivative) $76.7M $50.2M $45.7M
Net unrealized appreciation (non-derivative) $38.1M $-146M $35.6M

The three months of the reporting period, as filed; month 3 ends August 31, 2026.

Filing details

Registrant
Mfs Series Trust I
Registrant CIK
798244
Registrant LEI
549300QRB5FQ35HH3533
Series
MFS New Discovery Fund
Series ID
S000000765
Series LEI
ZVEMRLDGMDO1D1VDSU87
SEC file number
811-04777
Address
111 HUNTINGTON AVENUE, BOSTON, US-MA, 02199, US
Phone
617-954-5000
Form
NPORT-P
Filed
October 26, 2026
Report period ends
August 31, 2026
Report month ends
August 31, 2026
Accession number
000141036826108151
Holding Value % of net assets
Mfs Institutional Money Market Portfolio EC $84.6M 3.95%
Caci International Inc EC $54.1M 2.53%
Ligand Pharmaceuticals Inc EC $50M 2.33%
Jp Morgan Us Government Money Market Fund STIV $48.8M 2.28%
Merit Medical Systems Inc EC $44.9M 2.10%
Charles River Laboratories International Inc EC $41.9M 1.96%
Chefs' Warehouse Inc/the EC $40.7M 1.90%
Waystar Holding Corp EC $35.2M 1.64%
Moog Inc EC $35.1M 1.64%
Advanced Energy Industries Inc EC $34.9M 1.63%
Ssr Mining Inc EC $34.7M 1.62%
Gfl Environmental Inc EC $31.8M 1.48%
Littelfuse Inc EC $31.7M 1.48%
Donaldson Co Inc EC $31.6M 1.47%
Box Inc EC $30.4M 1.42%
James Hardie Industries PLC EC $30.3M 1.42%
Qxo Inc EC $30.2M 1.41%
Element Solutions Inc EC $29.4M 1.37%
Ttm Technologies Inc EC $29M 1.35%
Integer Holdings Corp EC $28.9M 1.35%
Knife River Corp EC $28.7M 1.34%
Oceaneering International Inc EC $28.7M 1.34%
Finning International Inc EC $28.6M 1.33%
Ccc Intelligent Solutions Holdings Inc EC $27.4M 1.28%
Viasat Inc EC $26.4M 1.23%
Ufp Technologies Inc EC $26.2M 1.22%
Terreno Realty Corp EC $26M 1.21%
Timken Co/the EC $26M 1.21%
Lincoln International Inc EC $24M 1.12%
Matador Resources Co EC $24M 1.12%
Digi International Inc EC $23.9M 1.12%
Simpson Manufacturing Co Inc EC $23.7M 1.11%
Pjt Partners Inc EC $23.6M 1.10%
Kiniksa Pharmaceuticals International PLC EC $23.4M 1.09%
Brunswick Corp/de EC $22.8M 1.07%
Siteone Landscape Supply Inc EC $21.4M 1.00%
Ascendis Pharma A/s EC $21.4M 1.00%
Ryman Hospitality Properties Inc EC $21.2M 0.99%
Wisdomtree Inc EC $20.6M 0.96%
Jfrog Ltd EC $20M 0.93%
Flowserve Corp EC $19.4M 0.90%
Guardant Health Inc EC $19.1M 0.89%
Installed Building Products Inc EC $19.1M 0.89%
Heartflow Inc EC $19M 0.89%
Semtech Corp EC $18.4M 0.86%
Kymera Therapeutics Inc EC $17.9M 0.84%
Patrick Industries Inc EC $17.9M 0.84%
Schrodinger Inc/united States EC $17.7M 0.83%
Minimed Group Inc EC $17.6M 0.82%
Antero Resources Corp EC $17.2M 0.80%
Birkenstock Holding PLC EC $17.1M 0.80%
Pulse Biosciences Inc EC $17.1M 0.80%
Leonardo Drs Inc EC $16.8M 0.78%
Praxis Precision Medicines Inc EC $16.7M 0.78%
Atricure Inc EC $16.5M 0.77%
Npk International Inc EC $16.5M 0.77%
Formfactor Inc EC $16.4M 0.77%
Radnet Inc EC $16.2M 0.76%
Zeta Global Holdings Corp EC $16.1M 0.75%
Ionis Pharmaceuticals Inc EC $15.8M 0.74%

Showing top 60 of 118 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support